Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible?

Obesity Surgery

Volumn 24, Issue 11, 2014, Pages 1856-1861

  Ishida, Robson K ^a   Faintuch, Joel ^a   Ribeiro, Adriana Safatle ^a   Ribeiro, Ulysses ^a   Cecconello, Ivan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aerobic bacteria; Anaerobic bacteria; Bacterial overgrowth; Bariatric surgery; Double balloon enteroscopy; Fasting blood glucose; Gastric bypass; Intestinal microbiome; Liver enzymes; Roux en Ygastric bypass

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; LIPID; PANCREAS ENZYME; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL OVERGROWTH; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DOUBLE BALLOON ENTEROSCOPY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHESIS; INTESTINE FLORA; LIVER FUNCTION; MALE; METABOLIC CAPACITY; MICROBIOME; MORBID OBESITY; PHENOTYPE; QUANTITATIVE ANALYSIS; ROUX Y ANASTOMOSIS; STOMACH JUICE; STOMACH POUCH; WEIGHT REDUCTION; ADVERSE EFFECTS; BLOOD; LIVER; METABOLISM; MICROBIOLOGY; OBESITY, MORBID; PROCEDURES; PROSPECTIVE STUDY; STOMACH; STOMACH BYPASS;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; FEMALE; GASTRIC BYPASS; HUMANS; LIVER; MALE; OBESITY, MORBID; PROSPECTIVE STUDIES; STOMACH; WEIGHT LOSS;

EID: 84917674121     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1277-z     Document Type: Article

References (29)

1. Schmalstieg Jr FC, Goldman AS. Ilya Ilich Metchnikoff (1845-1915) and Paul Ehrlich (1854-1915): the centennial of the 1908 Nobel Prize in Physiology or Medicine. J Med Biogr. 2008;16:96–103.
2. Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590–8.
3. Karlsson F, Tremaroli V, Nielsen J, et al. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013;62:3341–9.
4. Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–8.
5. Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011;9:461–9.
6. Yu D, Cheeseman F, Vanner FS. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–40.
7. Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178–41.
8. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6. e7.
9. Ockeloen LE, Deckers-Kocken JM. Short- and long-term effects of a lactose-restricted diet and probiotics in children with chronic abdominal pain: a retrospective study. Complement Ther Clin Pract. 2012;18:81–4.
10. Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371–7.
11. Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–87.
12. Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56:1524–34.
13. Madrid AM, Poniachik J, Quera R, et al. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011;56:155–60.
14. Machado JD, Campos CS, Lopes Da Silva C, et al. Intestinal bacterial overgrowth after Roux-em-Y gastric bypass. Obes Surg. 2007;17:1529–33.
15. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483–90.
16. Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107:730–5.
17. George NS, Sankineni A. Parkman HP. Dig Dis Sci: Small intestinal bacterial overgrowth in gastroparesis; 2012.
18. Klaus A, Weiss H, Kreczy A, et al. A new biliodigestive anastomosis technique to prevent reflux and stasis. Am J Surg. 2001;182:52–7.
19. Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28:293–8.
20. Corrodi P. Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infec Dis. 1984;6 Suppl 1:S80–4.
21. Leung FW, Drenick EJ, Stanley TM. Intestinal bypass complications involving the excluded bowel segment. Am J Gastroenterol. 1982;77:67–72.
22. Rana SV, Sharma S, Kaur J, et al. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243–7.
23. Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63:1–9.
24. Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198–204.
25. Shin DW, Kwon HT, Kang JM, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–5.
26. Steineman DC, Bueter M, Schiesser M, Amygdalos I, Clavien PA, Nocito A. Management of anastomotic ulcers after Roux-en-Y Gastric Bypass: results of an International Survey. Obes Surg 2013 Dec 18
27. Petrof EO, Claud EC, Gloor GB, et al. Microbial ecosystems therapeutics: a new paradigm in medicine ? Benef Microbes. 2013;4:53–65.
28. Allen-Vercoe E, Reid G, Viner N, et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol. 2012;26:457–62.
29. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1:3–9.